Warning: Your browser doesn't support all of the features in this Web site. Please view our accessibility page for more details.
The HRB Clinical Research Facility, Galway (CRFG) is a joint venture between Galway University Hospitals (GUH) and National University of Ireland, Galway (NUIG) and has been in operation since March 2008. The CRFG provides the infrastructure, physical space, facilities, expertise and culture needed to optimally support patient-focused research studies and clinical studies aimed at understanding a range of diseases and translating the knowledge obtained through this research work into reimbursed, regulatory approved advances in patient care as speedily as possible.
Introductory Course in Biostatistics
Advanced Course in Biostatistics
Please see http://jama.ama-assn.org/content/306/20/2229 for publication
Irish Times article on publication
Director of CRFG Prof. Frank Giles has opened new clinical study for a rare but devastating type of bone marrow cancer, click here for details
The HRB Clinical Research Facility Galway has enrolled the first patient onto a clinical trial for that for Galway company Marvao Medical devices. The innovative device, a catheter designed to reduce the risk of infection has been placed in a human patient for the first time this month (April 2011). See the Irish Times article for more information.
Professor Francis J. Giles has been awarded the Annual Saint Luke's Silver Award by the Royal Academy of Medicine in Ireland. This is this highest honour bestowed by the Academy and Professor Giles is the first NUI Galway recipient. Professor Giles also delivered the 36th Saint Luke's Lecture, entitled 'Optimising Ireland's Contribution to Curing Cancer'. The Saint Luke's Lecture is sponsored by the Acadmey and Saint Luke's Hospital. Please see the Royal Academy of Medicine in Ireland website for addtional information.
HRB funded researcher Dr. Andrew Murphy, Professor of General Practice at NUI Galway and Principal Investigator with the HRB Clinical Research Facility, Galway at NUI Galway, recently won the Royal Academy of Medicine Ireland (RAMI) award for best researcher paper in 2010. Additional information is available here.
At a recent public information night on stroke and dementia in the Ardilaun hotel Professor Martin O'Donnell outlined the 10 most important risk factors to focus on in the fight to prevent stroke. These factors account for over 90% of stroke risk, the most important of which was reducing high blood pressure. See Galway Advertiser for more details.
See Irish Times and Galway City Tribune for details of the recently opened clinical trial for a novel anti-cancer drug.
Please see interviews with Irish Times and Galway City Tribune for details about upcoming clinical trial.
Prof. Martin O'Donnell led the standardised case-control study which was undertaken in 22 countries between March 1, 2007, and April 23, 2010. Cases were patients with acute first stroke (within 5 days of symptoms onset and 72 h of hospital admission). Controls had no history of stroke, and were matched with cases for age and sex. All participants completed a structured questionnaire and a physical examination, and most provided blood and urine samples.
The findings suggest that ten risk factors are associated with 90% of the risk of stroke. Targeted interventions that reduce blood pressure and smoking, and promote physical activity and a healthy diet, could substantially reduce the burden of stroke.
Please see http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(10)60834-3/fulltext for full text.
Publicity arising from publication -
Irish Times article at http://www.irishtimes.com/newspaper/ireland/2010/0619/1224272868957.html

nuigalway.ie
